Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.
- DOI
- 10.1007/s13760-026-03106-9
- Published
- 2026 Jun 18
- Container
- Acta neurologica Belgica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13760-026-03106-9,
title = {Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.},
author = {Khodadadi S and Rezaeimanesh N and Varzandi T and Rezaei A and Hamidi M and Montazeri-Shatouri R and Mohammadi Lapevandani M and Sahraian MA and Naser Moghadasi A},
year = {2026},
journal = {Acta neurologica Belgica},
doi = {10.1007/s13760-026-03106-9},
url = {https://doi.org/10.1007/s13760-026-03106-9}
}RIS
TY - JOUR TI - Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis. AU - Khodadadi S AU - Rezaeimanesh N AU - Varzandi T AU - Rezaei A AU - Hamidi M AU - Montazeri-Shatouri R AU - Mohammadi Lapevandani M AU - Sahraian MA AU - Naser Moghadasi A PY - 2026 JO - Acta neurologica Belgica DO - 10.1007/s13760-026-03106-9 UR - https://doi.org/10.1007/s13760-026-03106-9 ER -
APA
S, K., N, R., T, V., A, R., M, H., R, M., M, M. L., MA, S., & A, N. M. (2026). Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.. Acta neurologica Belgica. https://doi.org/10.1007/s13760-026-03106-9
Source records
- pubmed · retrieved 2026-09-26T04:26:15.341Z